XERIS BIOPHARMA HOLDINGS, INC. Deferred Income Tax Liabilities, Net
XERIS BIOPHARMA HOLDINGS, INC. (XERS) had Deferred Income Tax Liabilities, Net of $0 as of 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2025-03-06
- 2024-12-31: Deferred Income Tax Liabilities, Net $0.00.
- 2024-09-30: Deferred Income Tax Liabilities, Net $0.00.
- 2024-06-30: Deferred Income Tax Liabilities, Net $3.32M.
- 2024-03-31: Deferred Income Tax Liabilities, Net $2.58M.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-06 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-08 |
| 2024-06-30 | $3.32M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $2.58M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $2.27M 10-K · filed 2025-03-06 |
| 2023-09-30 | $2.50M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $2.84M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $3.52M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $3.52M 10-K · filed 2024-03-06 |
| 2022-09-30 | $3.86M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $4.20M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $4.53M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $4.94M 10-K · filed 2023-03-08 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |